Sexual and preventive behaviors associated with HAV, HBV, and HPV vaccine hesitancy among men who have sex with men in France.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: ppublish

Résumé

Vaccination coverage against hepatitis A virus (HAV), hepatitis B virus (HBV), and human papillomaviruses (HPV) is insufficient among men who have sex with men (MSM), partly because of their high prevalence of vaccine hesitancy (VH) specific to these vaccines. This study aimed to investigate determinants of specific VH in MSM, focusing on characteristics of their sexual activity, propensity to use prevention tools and medical care, disclosure of sexual orientation to health care professionals (HCPs), and perceived stigmatization. A cross-sectional electronic survey (February - August 2022) collected perceptions of HBV, HAV, and HPV, and of their respective vaccines among 3,730 French MSM and enabled the construction of a specific VH variable. Using agglomerative hierarchical cluster analysis, we constructed a typology of MSM sexual and prevention practices. We identified three MSM clusters (low- (C1, 24%), moderate- (C2, 41%), and high- (C3, 35%) "sexual activity/medical engagement") that showed an increasing gradient in the use of medical prevention with regular medical care and exposure to high-risk sexual practices. A multiple ordinal logistic regression showed that overall specific VH was higher in the C1 cluster and in men who had not informed their physician of their sexual orientation. This typology could usefully help to adapt vaccination communication strategies for MSM prevention program according to patients' profiles. HCPs should be encouraged and trained to ask men about their sexual practices and to provide appropriate vaccination recommendations nonjudgmentally.

Identifiants

pubmed: 38783608
doi: 10.1080/21645515.2024.2348845
doi:

Substances chimiques

Papillomavirus Vaccines 0
Hepatitis B Vaccines 0
Hepatitis A Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2348845

Auteurs

Chloé Cogordan (C)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Lisa Fressard (L)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Emeline Brosset (E)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Aurélie Bocquier (A)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.
Inserm, INSPIIRE, Université de Lorraine, Nancy, France.

Annie Velter (A)

Santé publique France (The French Public Health Agency), Saint-Maurice, France.
Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Margot Annequin (M)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.
Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Michel Bourrelly (M)

Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Jean Constance (J)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

David Michels (D)

AIDES, Pantin, France.
Laboratoire de recherche communautaire, Coalition PLUS, Pantin, France.

Marion Mora (M)

Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Stéphane Morel (S)

AIDES, Paris, France.

Camilla Oliveri (C)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.
Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Gwenaëlle Maradan (G)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Cyril Berenger (C)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Bruno Spire (B)

Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Pierre Verger (P)

ORS PACA, Southeastern Health Regional Observatory, Marseille, France.
Unité des Virus Émergents, UVE: Aix-Marseille Univ Università di Corsica, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH